Health/Wellness Granata Bio Secures $15M Series A+ to Advance Reproductive Health InnovationsBy Leslie Scotland-StewartJanuary 15, 20250 Granata Bio Secures $15 Million in Series A+ Funding Granata Bio Corporation, a Boston-based biopharmaceutical firm dedicated to enhancing the…
Health/Wellness Voices for Change: Pregnant Women, Judges, and Activists Shape Reproductive Health in 2024By Leslie Scotland-StewartJanuary 3, 20250 In 2024, following a critical election that took place nearly two years after the U.S. Supreme Court rescinded federal abortion…
